β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis-Reference-Cited by-同舟云学术

β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

Published:2017-01-01 Issue:1 Volume:32 Page:832-840
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Aspatwar Ashok¹,Hammarén Milka¹,Koskinen Sanni¹,Luukinen Bruno¹,Barker Harlan¹,Carta Fabrizio²,Supuran Claudiu T.²,Parikka Mataleena¹,Parkkila Seppo¹³

Affiliation:

1. Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland;

2. Neurofarba Department, Sezione di Chimica Farmaceutica e Nutraceutica, Università degli Studi di Firenze, Sesto Fiorentino (Firenze), Italy;

3. Fimlab Ltd. and Tampere University Hospital, Tampere, Finland

Funder

Jane & Aatos Erkko Foundation

Sigrid Jusélius Foundation

Finnish Cultural Foundation

Academy of Finland

Tampere Tuberculosis Foundation

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/14756366.2017.1332056

Reference30 articles.

1. Insights into bacterial CO2 metabolism revealed by the characterization of four carbonic anhydrases in Ralstonia eutropha H16

2. WHO. Global Tuberculosis Report 2016. ISBN 978 92 4 156539 4 2016:1-214.

3. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

4. TubercuList – 10 years after

5. Identification of Bicarbonate as a Trigger and Genes Involved with Extracellular DNA Export in Mycobacterial Biofilms

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating molecular mechanism and chemical space of chalcones through biological networks and machine learning approaches;Computational and Structural Biotechnology Journal;2024-12

2. Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism;Computers in Biology and Medicine;2024-10

3. A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors;Frontiers in Pharmacology;2024-09-02

4. Embryonic and larval zebrafish models for the discovery of new bioactive compounds against TB;Drug Discovery Today;2024-09

5. WITHDRAWN: Physiological modeling into the metaverse of Mycobacterium Tuberculosis Beta CA inhibition mechanism;2024-05-31